Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).

European journal of medicinal chemistry 20140623

Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.

Heart rhythm 20131101

Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect.

Journal of cardiovascular electrophysiology 20130801

Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone.

Toxicological sciences : an official journal of the Society of Toxicology 20130201

Drug safety evaluation of dronedarone in atrial fibrillation.

Expert opinion on drug safety 20121101

Dronedarone reduces arterial thrombus formation.

Basic research in cardiology 20121101

Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20121101

Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.

Naunyn-Schmiedeberg's archives of pharmacology 20121001

The emerging role of amiodarone and dronedarone in Chagas disease.

Nature reviews. Cardiology 20121001

[Dronedarone in high-risk patients with atrial fibrillation : PALLAS study].

Der Internist 20121001

[New antiarrhythmic drugs for the treatment of atrial fibrillation].

Giornale italiano di cardiologia (2006) 20121001

[Update 2012: new European guidelines for atrial fibrillation].

MMW Fortschritte der Medizin 20120910

Atrial fibrillation and heart failure in the elderly.

Heart failure reviews 20120901

Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.

The American journal of cardiology 20120815

Recent clinical trials in atrial fibrillation in hypertensive patients.

Current hypertension reports 20120801

Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.

Clinical therapeutics 20120801

Atrial fibrillation: new drugs, devices, and procedures.

Cleveland Clinic journal of medicine 20120801

Virtual tissue engineering of the human atrium: modelling pharmacological actions on atrial arrhythmogenesis.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120716

A 73-year-old man with interstitial lung disease due to dronedarone.

American journal of respiratory and critical care medicine 20120715

Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.

Pacing and clinical electrophysiology : PACE 20120701

Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs.

British journal of pharmacology 20120601

Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.

Journal of cardiovascular pharmacology 20120601

Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.

Cardiovascular drugs and therapy 20120601

Efficacy and safety profile of dronedarone in clinical practice. Preliminary results of the Magdeburg Dronedarone Registry.

International journal of cardiology 20120531

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

The Cochrane database of systematic reviews 20120516

Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.

Journal of cardiovascular electrophysiology 20120501

[Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice].

Giornale italiano di cardiologia (2006) 20120501

rac-Methyl 2-(2-formyl-4-nitro-phen-oxy)hexa-noate.

Acta crystallographica. Section E, Structure reports online 20120501

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

Expert opinion on pharmacotherapy 20120401

Fatal lung toxic effects related to dronedarone use.

Archives of internal medicine 20120326

Dronedarone use and fatal lung toxic effects?

Archives of internal medicine 20120326

Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.

International journal of cardiology 20120322

Dronedarone in high-risk permanent atrial fibrillation.

The New England journal of medicine 20120322

Dronedarone in high-risk permanent atrial fibrillation.

The New England journal of medicine 20120322

Dronedarone in high-risk permanent atrial fibrillation.

The New England journal of medicine 20120322

[Rhythm---control in atrial fibrillation].

MMW Fortschritte der Medizin 20120322

Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.

Journal of cardiovascular pharmacology and therapeutics 20120301

[Atrial fibrillation : new anticoagulants and antiarrhythmic drugs].

Herz 20120301

Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.

Expert review of cardiovascular therapy 20120301

Dronedarone-current status in management of atrial fibrillation.

Indian heart journal 20120301

[Prevention of cardioembolic stroke].

Neurologia (Barcelona, Spain) 20120301

Atrial fibrillation.

Lancet (London, England) 20120218

Second chance for dronedarone after recent setback?

Lancet (London, England) 20120218

Dronedarone: an overview.

Annals of medicine 20120201

Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.

Journal of cardiovascular pharmacology 20120101

Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal.

PharmacoEconomics 20120101

Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation.

Yonsei medical journal 20120101

Benefit-risk assessment of current antiarrhythmic drug therapy of atrial fibrillation.

Clinical cardiology 20120101

[Amiodarone and thyroid dysfunction].

Medicina 20120101

Atrial fibrillation: established and innovative methods of evaluation and treatment.

Deutsches Arzteblatt international 20120101

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.

Clinical interventions in aging 20120101

Toward a New Gold Standard for Early Safety: Automated Temperature-Controlled hERG Test on the PatchLiner.

Frontiers in pharmacology 20120101

Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors.

Journal of medical economics 20120101

Who protects physicians and patients from guidelines?

Cardiology 20120101

Cost considerations in the management of atrial fibrillation - impact of dronedarone.

ClinicoEconomics and outcomes research : CEOR 20120101

Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

Substance abuse treatment, prevention, and policy 20120101

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

The Canadian journal of cardiology 20120101

[Update on current care guidelines: atrial fibrillation].

Duodecim; laaketieteellinen aikakauskirja 20120101

Costs and clinical consequences of suboptimal atrial fibrillation management.

ClinicoEconomics and outcomes research : CEOR 20120101

Dronedarone for recurrent ventricular tachycardia: a real alternative?

Indian pacing and electrophysiology journal 20120101

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

PloS one 20120101

Addressing the management of atrial fibrillation - a systematic review of the role of dronedarone.

International journal of general medicine 20120101

Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration.

Free radical biology & medicine 20111215

Dronedarone in atrial fibrillation--Jekyll and Hyde?

The New England journal of medicine 20111215

Dronedarone in high-risk permanent atrial fibrillation.

The New England journal of medicine 20111215

Safety of dronedarone (Multaq).

The Medical letter on drugs and therapeutics 20111212

Reduction of cerebral infarct size by dronedarone.

Cardiovascular drugs and therapy 20111201

[Who protects physicians and patients from guidelines?].

Deutsche medizinische Wochenschrift (1946) 20111201

Dronedarone: a new hope for stroke prevention in atrial fibrillation?

American journal of cardiovascular drugs : drugs, devices, and other interventions 20111201

Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20111201

The management of patients with atrial fibrillation and dronedarone's place in therapy.

Advances in therapy 20111201

Dronedarone trial stopped due to excess mortality.

Prescrire international 20111201

[Atrial fibrillation. PALLAS study: when dronedarone becomes a risk].

MMW Fortschritte der Medizin 20111201

Atrial fibrillation: Dronedarone not suitable for patients with permanent AF.

Nature reviews. Cardiology 20111129

Rationale and current perspective for early rhythm control therapy in atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20111101

Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype.

Biochemical pharmacology 20111101

Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111015

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Clinical research in cardiology : official journal of the German Cardiac Society 20111001

Update on the management of atrial fibrillation: anticoagulation and medical therapy.

Current cardiology reports 20111001

The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C.

Biochimica et biophysica acta 20111001

Drug-induced heart failure.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111001

Evaluation of dronedarone use in the US patient population between 2009 and 2010: a descriptive study using a claims database.

Clinical therapeutics 20111001

Dronedarone: liver damage and cardiac disorders. Negative harm-benefit balance.

Prescrire international 20111001

Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.

Heart failure reviews 20110901

Elevated international normalized ratio associated with use of dronedarone and warfarin.

The Annals of pharmacotherapy 20110901

Update on anti-coagulation in atrial fibrillation.

QJM : monthly journal of the Association of Physicians 20110901

Mixed learning algorithms and features ensemble in hepatotoxicity prediction.

Journal of computer-aided molecular design 20110901

Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation?

Naunyn-Schmiedeberg's archives of pharmacology 20110801

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110801

Hospitalization: a relevant endpoint in atrial fibrillation management?

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110801

Is antiarrhythmic treatment in the elderly different? a review of the specific changes.

Drugs & aging 20110801

Acute liver failure associated with dronedarone.

Circulation. Arrhythmia and electrophysiology 20110801

Atrial fibrillation: outpatient presentation and management.

Circulation 20110705

Effects of dronedarone on clinical outcomes in patients with lone atrial fibrillation: pooled post hoc analysis from the ATHENA/EURIDIS/ADONIS studies.

Journal of cardiovascular electrophysiology 20110701

Acute T3 treatment protects the heart against ischemia-reperfusion injury via TRα1 receptor.

Molecular and cellular biochemistry 20110701

The impact of dronedarone on lone atrial fibrillation: perhaps not such a 'benign' arrhythmia?

Journal of cardiovascular electrophysiology 20110701

Antiarrhythmic drugs for atrial fibrillation.

Expert opinion on pharmacotherapy 20110601

Post-ATHENA and beyond.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20110601

Treating arrhythmias: an expert opinion.

Expert opinion on pharmacotherapy 20110601

Reduction of myocardial infarct size by dronedarone in pigs--a pleiotropic action?

Cardiovascular drugs and therapy 20110601

Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice.

Expert opinion on pharmacotherapy 20110601

Atrial fibrillation: epidemiology, prognosis and therapy.

Minerva medica 20110601

Dronedarone for atrial fibrillation therapy.

Expert review of cardiovascular therapy 20110601

Effect of triiodothyronine on antidepressant screening tests in mice and on presynaptic 5-HT1A receptors: mediation by thyroid hormone α receptors.

The Journal of pharmacology and experimental therapeutics 20110501

Comment: worsening heart failure in the setting of dronedarone initiation.

The Annals of pharmacotherapy 20110501

Methyl 4-(3-chloro-prop-oxy)benzoate.

Acta crystallographica. Section E, Structure reports online 20110501

Effect of dronedarone on Na+, Ca2+ and HCN channels.

Naunyn-Schmiedeberg's archives of pharmacology 20110401

Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).

The American journal of cardiology 20110401

Antiarrhythmic drugs management in patients with atrial fibrillation: the new guidelines.

Minerva cardioangiologica 20110401

In brief: FDA warning on dronedarone (Multaq).

The Medical letter on drugs and therapeutics 20110307

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110301

Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110301

Dronedarone for atrial fibrillation: How does it compare with amiodarone?

Cleveland Clinic journal of medicine 20110301

Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death.

Future cardiology 20110301

[Perspectives and recommendations for the anti-arrhythmic treatment of atrial fibrillation: focus on dronedarone].

Revue medicale de Liege 20110301

Suppression of ventricular tachycardia with dronedarone: a case report.

Journal of cardiovascular electrophysiology 20110201

A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110201

Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?

Pacing and clinical electrophysiology : PACE 20110201

Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling.

Current drug targets 20110201

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20110201

The pharmaceutical pipeline for atrial fibrillation.

Annals of medicine 20110201

[Epidemiology, clinical picture and management of atrial fibrillation].

Der Nervenarzt 20110201

An important indirect drug interaction between dronedarone and warfarin that may be extrapolated to other drugs that can alter gastrointestinal function.

American heart journal 20110201

What's new in...atrial fibrillation. Is dronedarone more effective than amiodarone?

JAAPA : official journal of the American Academy of Physician Assistants 20110201

Dronedarone.

Drugs of today (Barcelona, Spain : 1998) 20110201

Ethyl 2-(2-hy-droxy-5-nitro-phen-yl)acetate.

Acta crystallographica. Section E, Structure reports online 20110201

Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.

Expert opinion on pharmacotherapy 20110101

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Heart rhythm 20110101

Sinus rhythm restoration and treatment success: insight from recent clinical trials.

Clinical cardiology 20110101

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.

Drug design, development and therapy 20110101

Electrophysiology and adult congenital heart disease: advances and options.

Progress in cardiovascular diseases 20110101

Comparing the 2010 North American and European atrial fibrillation guidelines.

The Canadian journal of cardiology 20110101

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.

The Canadian journal of cardiology 20110101

An Observational, Prospective Survey Assessing the Control of Atrial Fibrillation in Asia Pacific: Rationale and Design of the RecordAF-AP Registry.

Clinical Medicine Insights. Cardiology 20110101

Dronedarone for the management of atrial fibrillation.

Swiss medical weekly 20110101

Cost of AF Ablation: Where Do We Stand?

Cardiology research and practice 20110101

[The research practice of anti-arrhythmic agents targeting on potassium ion channel].

Yao xue xue bao = Acta pharmaceutica Sinica 20110101

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation.

Vascular health and risk management 20110101

[Update on current care guidelines: atrial fibrillation].

Duodecim; laaketieteellinen aikakauskirja 20110101

[The role of dronedarone in the contemporary atrial fibrillation treatment].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20110101

Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.

BMC cardiovascular disorders 20110101

Pharmacological management of atrial fibrillation: one, none, one hundred thousand.

Cardiology research and practice 20110101

[Amiodarone and thyroid function].

Kardiologia polska 20110101

Combination ranolazine and dronedarone to suppress atrial fibrillation.

Reviews in cardiovascular medicine 20110101

Management of patients with atrial fibrillation: specific considerations for the old age.

Cardiology research and practice 20110101

Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.

PloS one 20110101

Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter.

Clinical Medicine Insights. Cardiology 20110101

[New drugs for small animals in 2010].

Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20110101

Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.

Journal of cardiovascular pharmacology and therapeutics 20101201

Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation.

Journal of cardiovascular pharmacology and therapeutics 20101201

Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure.

Cardiovascular drugs and therapy 20101201

Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.

Expert opinion on pharmacotherapy 20101201

Treatment of atrial fibrillation in 2010 and beyond.

Journal of cardiovascular pharmacology and therapeutics 20101201

A new agent for atrial fibrillation: electrophysiological properties of dronedarone.

Journal of cardiovascular pharmacology and therapeutics 20101201

A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.

Journal of cardiovascular pharmacology and therapeutics 20101201

Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.

Journal of cardiovascular pharmacology and therapeutics 20101201

[Dronedarone].

Herzschrittmachertherapie & Elektrophysiologie 20101201

[New developments in the antiarrhythmic therapy of atrial fibrillation].

Herzschrittmachertherapie & Elektrophysiologie 20101201

Are neurological and other side effects truly less frequent in dronedarone compared to amiodarone?

Journal of cardiovascular electrophysiology 20101201

Advances in the treatment of atrial fibrillation.

Minerva cardioangiologica 20101201

[Management of atrial fibrillation, what to know on old and new antiarrhythmics].

Annales de cardiologie et d'angeiologie 20101201

[Current management of atrial fibrillation: rhythm or rate control and thoughts about a new treatment paradigm].

Annales de cardiologie et d'angeiologie 20101201

Dronedarone for atrial fibrillation?

Drug and therapeutics bulletin 20101101

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

Journal of the American College of Cardiology 20101012

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

Journal of the American College of Cardiology 20101005

New approaches to atrial fibrillation management: treat the patient, not the ECG.

Cardiovascular therapeutics 20101001

Dronedarone and vitamin K antagonists: a review of drug-drug interactions.

American heart journal 20101001

Dronedarone for the treatment of atrial fibrillation and atrial flutter.

Health technology assessment (Winchester, England) 20101001

[Treatment of atrial fibrillation: when to use drugs or to perform ablation].

Giornale italiano di cardiologia (2006) 20101001

Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.

Heart rhythm 20100901

Amiodarone and dronedarone: the worker bee and the drone?

Heart rhythm 20100901

Worsening heart failure in the setting of dronedarone initiation.

The Annals of pharmacotherapy 20100901

Role of dronedarone in atrial fibrillation: more questions than answers.

Pharmacotherapy 20100901

Dronedarone: a new antiarrhythmic agent.

Pharmacotherapy 20100901

Dronedarone: an alternative to amiodarone?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100901

[Advances in the prevention of cerebral ischaemia due to atrial fibrillation].

Neurologia (Barcelona, Spain) 20100901

The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.

Journal of cardiovascular electrophysiology 20100801

Prevention of stroke in patients with atrial fibrillation: the role of new antiarrhythmic and antithrombotic drugs.

Cerebrovascular diseases (Basel, Switzerland) 20100801

Dronedarone: NICE enough?

Expert review of cardiovascular therapy 20100801

Dronedarone in patients with atrial fibrillation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 20100801

Dronedarone: where does it fit in the treatment of atrial fibrillation?

South Dakota medicine : the journal of the South Dakota State Medical Association 20100801

Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.

Prescrire international 20100801

The dronedarone odyssey.

Prescrire international 20100801

Dronedarone: a safety comparison to amiodarone.

Current drug safety 20100702

Dronedarone in patients with congestive heart failure: insights from ATHENA.

European heart journal 20100701

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

Journal of cardiovascular electrophysiology 20100601

Dronedarone: an emerging therapy for atrial fibrillation.

Therapeutic advances in cardiovascular disease 20100601

A perspective on DIONYSOS.

Journal of cardiovascular electrophysiology 20100601

Dronedarone: a review of characteristics and clinical data.

Critical pathways in cardiology 20100601

Thrombi of different pathologies: implications for diagnosis and treatment.

Current treatment options in cardiovascular medicine 20100601

New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100501

Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.

Journal of cardiovascular pharmacology 20100501

Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.

Clinical cardiology 20100501

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

Journal of the American College of Cardiology 20100413

New antiarrhythmic drugs for treatment of atrial fibrillation.

Lancet (London, England) 20100403

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

Journal of the American College of Cardiology 20100309

Dronedarone is superior to placebo the case for optimism.

Journal of the American College of Cardiology 20100309

The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.

Heart failure reviews 20100301

Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Naunyn-Schmiedeberg's archives of pharmacology 20100301

Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.

Heart (British Cardiac Society) 20100301

[Current antiarrhythmic drug therapy in atrial fibrillation].

Deutsche medizinische Wochenschrift (1946) 20100301

[Clinical profile of the new antiarrhythmic drug dronedarone].

Deutsche medizinische Wochenschrift (1946) 20100301

[Clinical pharmacology and electrophysiological properties of dronedarone].

Deutsche medizinische Wochenschrift (1946) 20100301

[Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?].

Deutsche medizinische Wochenschrift (1946) 20100301

FDA drug information that never reaches clinicians.

The New England journal of medicine 20100211

Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?

Current opinion in neurology 20100201

Atrial fibrillation. DIONYSOS study comparing dronedarone with amiodarone.

BMJ (Clinical research ed.) 20100119

Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.

Current opinion in cardiology 20100101

Effects of amiodarone therapy on thyroid function.

Nature reviews. Endocrinology 20100101

Efficacy and safety of dronedarone: a review of randomized trials.

Expert opinion on drug safety 20100101

Dronedarone--a new alternative for management of atrial fibrillation.

Recent patents on cardiovascular drug discovery 20100101

Atrial fibrillation: Dronedarone and amiodarone-the safety versus efficacy debate.

Nature reviews. Cardiology 20100101

Dronedarone: current evidence and future questions.

Cardiovascular therapeutics 20100101

[Comparison of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. Indirect meta-analysis].

Kardiologiia 20100101

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction.

Clinical interventions in aging 20100101

Forecasting drug utilization and expenditure in a metropolitan health region.

BMC health services research 20100101

Significant sirolimus and dronedarone interaction in a kidney transplant recipient.

The Annals of pharmacotherapy 20100101

Concept of the five 'A's for treating emergency arrhythmias.

Journal of emergencies, trauma, and shock 20100101

Treating critical supraventricular and ventricular arrhythmias.

Journal of emergencies, trauma, and shock 20100101

Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.

PloS one 20100101

[Ionic mechanisms of action of class III antiarrhythmic drugs].

Kardiologiia 20100101

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

Vascular health and risk management 20100101

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.

Vascular health and risk management 20100101

Atrial fibrillation after cardiac surgery.

Annals of cardiac anaesthesia 20100101

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation.

Core evidence 20100101

Dronedarone: from buzz to reality.

Archives of cardiovascular diseases 20100101

[New antiarrhythmic drugs for treatment of atrial fibrillation].

Duodecim; laaketieteellinen aikakauskirja 20100101

[Novel targets in the treatment of patients with atrial fibrillation: from elimination of symptoms to improvement of clinical outcomes].

Kardiologiia 20100101

The effect of acyclovir on the tubular secretion of creatinine in vitro.

Journal of translational medicine 20100101

Dronedarone: a new therapeutic alternative for cardiac arrhythmias.

Journal of young pharmacists : JYP 20100101

Amiodarone and thyroid.

Best practice & research. Clinical endocrinology & metabolism 20091201

Recent advances in the pharmacological treatment of cardiac arrythmias.

Drugs of today (Barcelona, Spain : 1998) 20091101

Dronedarone (Multaq) for atrial fibrillation.

The Medical letter on drugs and therapeutics 20091005

Dronedarone: a promising alternative for the management of atrial fibrillation.

Cardiovascular drugs and therapy 20091001

Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations.

European heart journal 20091001

Dronedarone.

Nature reviews. Drug discovery 20091001

New pharmacological agents for arrhythmias.

Circulation. Arrhythmia and electrophysiology 20091001

New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future.

Current treatment options in cardiovascular medicine 20091001

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

Circulation 20090929

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

Journal of the American College of Cardiology 20090915

Amiodarone or dronedarone for atrial fibrillation: too early to know the winner?

Journal of the American College of Cardiology 20090915

Dronedarone.

Drugs 20090820

Dronedarone.

Circulation 20090818

Dronedarone approved for atrial arrhythmias.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090815

Pharmacologic management of atrial fibrillation: established and emerging options.

Journal of managed care pharmacy : JMCP 20090801

Recent advances in pharmacotherapy of atrial fibrillation.

Indian journal of pharmacology 20090801

Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090615

Dronedarone in atrial fibrillation.

The New England journal of medicine 20090604

Dronedarone in atrial fibrillation.

The New England journal of medicine 20090604

Dronedarone in atrial fibrillation.

The New England journal of medicine 20090604

Dronedarone in atrial fibrillation.

The New England journal of medicine 20090604

[Dronedarone: the new antiarrythmic agent?].

Herzschrittmachertherapie & Elektrophysiologie 20090601

New pharmacological options for patients with atrial fibrillation: the ATHENA trial.

Revista espanola de cardiologia 20090501

Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.

Expert review of cardiovascular therapy 20090501

Dronedarone for atrial fibrillation--an odyssey.

The New England journal of medicine 20090430

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20090401

Alternatives to amiodarone: search for the Holy Grail.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20090401

Trial watch: novel antiarrhythmic agent shows promise in Phase III trial.

Nature reviews. Drug discovery 20090401

[The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies].

Kardiologia polska 20090401

Major recent trials in cardiovascular diseases.

Postgraduate medicine 20090301

Effect of dronedarone on cardiovascular events in atrial fibrillation.

The New England journal of medicine 20090212

Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.

European journal of heart failure 20090201

Benzofuran derivatives and the thyroid.

Clinical endocrinology 20090101

Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?

Current opinion in cardiology 20090101

Novel approaches for pharmacological management of atrial fibrillation.

Drugs 20090101

[How did ATHENA win ANDROMEDA? Results of the ATHENA].

Kardiologiia 20090101

Molecular genetics of atrial fibrillation.

Genome medicine 20090101

Atrial fibrillation: from ion channels to bedside treatment options.

Journal of electrocardiology 20090101

[Treatment of atrial fibrillation in heart failure].

Therapie 20090101

Dronedarone for atrial fibrillation: a new therapeutic agent.

Vascular health and risk management 20090101

Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.

Cardiology in review 20090101

Prasugrel hydrochloride, dronedarone, and saxagliptin hydrochloride.

Journal of the American Pharmacists Association : JAPhA 20090101

Can we improve outcomes in AF patients by early therapy?

BMC medicine 20090101

New advances and new questions in cardiovascular therapeutics.

American journal of therapeutics 20090101

Advances in the management of atrial fibrillation in congestive heart failure.

F1000 medicine reports 20090101

[Amiodaron for treatment of perioperative cardiac arrythmia: a broad spectrum antiarrythmetic agent?].

Der Anaesthesist 20081201

Dronedarone: a new treatment for atrial fibrillation.

Journal of cardiovascular electrophysiology 20081101

New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20081001

Amiodarone as paradigm for developing new drugs for atrial fibrillation.

Journal of cardiovascular pharmacology 20081001

New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?

The American journal of cardiology 20080922

Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.

European journal of heart failure 20080901

Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.

American heart journal 20080901

[Current pharmacological management of atrial fibrillation management by practice cardiologists - news from congress in Munich].

Kardiologia polska 20080901

Increased mortality after dronedarone therapy for severe heart failure.

The New England journal of medicine 20080619

Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes.

Naunyn-Schmiedeberg's archives of pharmacology 20080601

Pharmacotherapy for atrial arrhythmias: present and future.

Heart rhythm 20080601

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20080601

Concurrent Chagas' disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug.

Therapeutics and clinical risk management 20080601

Is dronedarone effective for the prevention of recurrent atrial fibrillation?

Nature clinical practice. Cardiovascular medicine 20080301

Update on atrial fibrillation: part II.

Clinical cardiology 20080301

Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.

Journal of cardiovascular electrophysiology 20080101

Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.

Cardiology journal 20080101

[Efficacy of dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. Results of the EURIDIS and ADONIS].

Kardiologiia 20080101

Atrial fibrillation after cardiac surgery: where are we now?

Indian pacing and electrophysiology journal 20080101

[Efficacy of dronedarone in cardiac failure due to severe left ventricular systolic dysfunction. Results of the ANDROMEDA].

Kardiologiia 20080101

Dronedarone in atrial fibrillation.

The New England journal of medicine 20071206

Dronedarone in atrial fibrillation.

The New England journal of medicine 20071206

Effect of dronedarone on renal function in healthy subjects.

British journal of clinical pharmacology 20071201

In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle.

Journal of cardiovascular pharmacology and therapeutics 20071201

New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?

American heart journal 20071101

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

The Cochrane database of systematic reviews 20071017

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

The New England journal of medicine 20070906

Maintaining sinus rhythm--making treatment better than the disease.

The New England journal of medicine 20070906

Acute in vitro effects of dronedarone, an iodine-free derivative, and amiodarone, on the rabbit sinoatrial node automaticity: a comparative study.

Journal of cardiovascular pharmacology and therapeutics 20070901

Na+/Ca2+ exchange inhibitors: a new class of calcium regulators.

Cardiovascular & hematological disorders drug targets 20070901

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin.

Biochemical pharmacology 20070801

New antiarrhythmic treatment of atrial fibrillation.

Expert review of cardiovascular therapy 20070701

Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.

European journal of pharmacology 20070614

Effect of amiodarone and dronedarone administration in rats on thyroid hormone-dependent gene expression in different cardiac components.

European journal of endocrinology 20070601

Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.

The Annals of pharmacotherapy 20070401

A review of the investigational antiarrhythmic agent dronedarone.

Journal of cardiovascular pharmacology and therapeutics 20070301

Pharmacological inhibition of TRalpha1 receptor potentiates the thyroxine effect on body weight reduction in rats: potential therapeutic implications in controlling body weight.

Diabetes, obesity & metabolism 20070101

Dronedarone: drondarone, SR 33589, SR 33589B.

Drugs in R&D 20070101

Dronedarone: in quest of the ideal antiarrhythmic drug.

Progress in cardiovascular nursing 20070101

Comment on dronedarone.

Journal of cardiovascular electrophysiology 20061201

Do we need pharmacological therapy for atrial fibrillation in the ablation era?

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20061201

Dronedarone: an emerging agent with rhythm- and rate-controlling effects.

Journal of cardiovascular electrophysiology 20060901

Medical management of atrial fibrillation: state of the art.

Journal of cardiovascular electrophysiology 20060901

Amiodarone: a multifaceted antiarrhythmic drug.

Current cardiology reports 20060901

Topics on the Na+/Ca2+ exchanger: pharmacological characterization of Na+/Ca2+ exchanger inhibitors.

Journal of pharmacological sciences 20060901

Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent.

Current opinion in investigational drugs (London, England : 2000) 20060901

Dose-dependent effects of oral dronedarone on the circadian variation of RR and QT intervals in healthy subjects: implications for antiarrhythmic actions.

Journal of cardiovascular pharmacology and therapeutics 20060901

[Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency].

Deutsche medizinische Wochenschrift (1946) 20060825

[Dronedarone establishes and maintains control of sinus rhythm].

Revue medicale suisse 20060823

Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5'-monophosphate- and iodine-independent mechanism.

Endocrinology 20060601

Dronedarone: a new antiarrhythmic agent.

Drugs of today (Barcelona, Spain : 1998) 20060201

Pharmacological treatment of atrial fibrillation: mechanisms of action and efficacy of class III drugs.

Current medicinal chemistry 20060101

This DAFNE is definitely not that DAFNE.

International journal of cardiology 20050525

[Safety of new anti-arrhythmic drugs].

Archives des maladies du coeur et des vaisseaux 20050401

A review of the pharmacokinetics, electrophysiology and clinical efficacy of dronedarone.

Future cardiology 20050301

In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.

Journal of cardiovascular pharmacology 20050201

Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1.

Thyroid : official journal of the American Thyroid Association 20050101

[Atrial fibrillation: choice of the method of pharmacological cardioversion].

Kardiologiia 20050101

The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

Cardiovascular drug reviews 20050101

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101

High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.

Biochemical and biophysical research communications 20041217

A benefit-risk assessment of class III antiarrhythmic agents.

Expert opinion on drug safety 20041101

[New anti-arrhythmics--hope or disappointment?].

Archives des maladies du coeur et des vaisseaux 20041101

Involvement of nitric oxide in amiodarone- and dronedarone-induced coronary vasodilation in guinea pig heart.

European journal of pharmacology 20040802

Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship.

American journal of physiology. Lung cellular and molecular physiology 20040801

Dronedarone: an amiodarone analogue.

Expert opinion on investigational drugs 20040401

Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.

Fundamental & clinical pharmacology 20040201

Oral class III antiarrhythmics: what is new?

Current opinion in cardiology 20040101

Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20040101

Theoretical possibilities for the development of novel antiarrhythmic drugs.

Current medicinal chemistry 20040101

Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.

British journal of pharmacology 20031101

IKr channel blockers: novel antiarrhythmic agents.

Current medicinal chemistry. Cardiovascular and hematological agents 20031001

Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes.

Journal of cardiovascular electrophysiology 20030801

Dronedarone for prevention of atrial fibrillation: a dose-ranging study.

European heart journal 20030801

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

The American journal of cardiology 20030320

Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence.

Endocrinology 20030201

Electrophysiologic characterization of dronedarone in guinea pig ventricular cells.

Journal of cardiovascular pharmacology 20030201

Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedarone.

Cardiovascular research 20030101

The JT-area indicates dispersion of repolarization in dogs with atrioventricular block.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20020601

Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart.

European journal of pharmacology 20020531

Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone.

Journal of cardiovascular pharmacology 20020501

Recent advances in arrhythmia therapy: treatment and prevention of atrial fibrillation.

Current opinion in pharmacology 20020401

New antiarrhythmic drugs for the treatment of atrial fibrillation.

Pacing and clinical electrophysiology : PACE 20020201

Five novel single nucleotide polymorphisms in the CYP2C8 gene, one of which induces a frame-shift.

Drug metabolism and pharmacokinetics 20020101

Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.

Circulation 20011127

Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts.

Journal of cardiovascular pharmacology 20011001

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone.

British journal of pharmacology 20010701

Dronedarone (Sanofi-Synthélabo).

IDrugs : the investigational drugs journal 20010501

Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.

Journal of cardiovascular pharmacology and therapeutics 20010101

Newer antiarrhythmic drugs.

Indian heart journal 20010101

Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction.

Journal of cardiovascular pharmacology 20000901